BGMHealthcare · Drug Manufacturers - Specialty & Generic

BGM Stock Forecast: BGM Group Ltd. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$0.26
−4.71% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 41 of 100 as at 12 Sept 2026 — in the lower half.

Market cap
$105.4M
Ticker Nerd rank
41 / 100
Median analyst target
Analysts covering
Total return, dividends reinvested
1W
−7.1%
1M
−9.6%
YTD
−92.9%
1Y
−96.5%
From 52W high
−97.8%
From 52W low
+5.2%
$0
$12
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BGM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BGM Group Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
41 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
84
Value
82
Size
74
Growth
55
Volatility
43
Accruals
37
Issuance
29
Revisions
25
Momentum
17

Quality (84): The business earns solid, repeatable profits on what it owns.

Momentum (17): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BGM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BGM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$2$4$6$8$10Oct 25Jan 26Apr 26Jul 26BGM

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BGM appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

BGM vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, BGM Group Ltd. returned −96.5% against +17.5% for the S&P 500, dividends included.

BGM vs S&P 500, last 12 monthsTotal return, rebased to 100
050100150Oct 25Jan 26Apr 26Jul 26BGMS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BGM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

BGM Group Ltd. (BGM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
15.0×

Cheaper than 46% of US stocks

Price / sales
2.2×

Cheaper than 50% of US stocks

Price / book
0.1×

Cheaper than 90% of US stocks

EV / EBITDA
−4.7×

Cheaper than 78% of US stocks

Growth & margins
Revenue growth (YoY)
69.8%

Higher than 90% of US stocks

Earnings growth (YoY)
Gross margin
Operating margin
−3.6%

Higher than 29% of US stocks

Net margin
−44.2%

Higher than 11% of US stocks

Returns & dividend
Return on equity
−7.4%

Higher than 37% of US stocks

Return on assets
−2.2%

Higher than 37% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

BGM Group Ltd. (BGM) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • BGM Group Ltd. has a market value of $105.4M and an enterprise value of $43.9M.

  • Shares outstanding: 200.6M.

  • Trailing P/E: 15.0×.

  • BGM Group Ltd. employs 298 people.

market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

BGM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDrug Manufacturers - Specialty & Generic
CompanyMarket capTKN rank
BGMBGM Group Ltd.$105.4M
41
CPIXCumberland Pharmaceuticals, Inc.$95.7M
84
ADCTADC Therapeutics SA$132.5M
74
CTORCitius Oncology, Inc.$85.3M
18
OGIOrganigram Global, Inc.$149.0M
41
LFCRLifecore Biomedical, Inc.$154.4M
3
ORGOOrganogenesis Holdings, Inc.$189.1M
50

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own BGM Group Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Frequently asked questions about BGM stock

How does Ticker Nerd's model rank BGM?

As at 12 Sept 2026, BGM Group Ltd. ranks 41 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (84 of 100).

What is the BGM stock forecast for 2030?

No analyst covering BGM Group Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BGM are extrapolating price history, which says nothing about the business.

How has BGM stock performed over the past year?

BGM Group Ltd. returned -96.5% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BGM Group Ltd. do?

BGM Group Ltd. Class A Ordinary Shares represent equity ownership in BGM Group Ltd., a holding company with operations in China across pharmaceuticals, chemicals, and related industrial products.

Company

About BGM Group Ltd.

BGM Group Ltd. Class A Ordinary Shares represent equity ownership in BGM Group Ltd., a holding company with operations in China across pharmaceuticals, chemicals, and related industrial products. The company’s current business activities include the manufacture and distribution of active pharmaceutical ingredients, traditional Chinese medicine derivatives, heparin products, sausage casing, and fertilizer products. BGM Group Ltd. also describes exposure to technology-focused areas such as AI applications, intelligent robots, algorithmic computing power, and cloud computing, reflecting a broader operating profile that spans healthcare and emerging technology themes. As a Class A share class, these ordinary shares carry voting rights and form part of the company’s capital structure used by public market investors to participate in the business. BGM Group Ltd. serves customers and counterparties primarily through its operating subsidiaries and variable interest entity structure in China.

CEO Mr. Chen Xin · 298 employees · China · https://www.bgmgroupltd.com